GlucoTrack Inc (GCTK) - Total Liabilities
Based on the latest financial reports, GlucoTrack Inc (GCTK) has total liabilities worth $3.24 Million USD as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See GlucoTrack Inc (GCTK) liquidity interval to measure how many days the company can operate on defensive assets alone.
GlucoTrack Inc - Total Liabilities Trend (2011–2025)
This chart illustrates how GlucoTrack Inc's total liabilities have evolved over time, based on quarterly financial data. See GlucoTrack Inc free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
GlucoTrack Inc Competitors by Total Liabilities
The table below lists competitors of GlucoTrack Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Clean Motion AB
ST:CLEMO
|
Sweden | Skr16.09 Million |
|
Nextgen
TA:NXGN
|
Israel | ILA11.20 Million |
|
SOLAI Limited
NYSE:SLAIY
|
USA | $9.08 Million |
|
Margaret Lake Diamonds Inc
V:DIA
|
Canada | CA$859.97K |
|
Future Supply Chain Solutions Limited
NSE:FSC
|
India | Rs3.32 Billion |
|
Osteopore Ltd
AU:OSX
|
Australia | AU$4.50 Million |
|
OFAL
NASDAQ:OFAL
|
USA | $8.89 Million |
Liability Composition Analysis (2011–2025)
This chart breaks down GlucoTrack Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see GlucoTrack Inc assets under control.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.46 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -1.86 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 2.16 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how GlucoTrack Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for GlucoTrack Inc (2011–2025)
The table below shows the annual total liabilities of GlucoTrack Inc from 2011 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $5.01 Million | -73.54% |
| 2024-12-31 | $18.93 Million | +1008.43% |
| 2023-12-31 | $1.71 Million | +41.39% |
| 2022-12-31 | $1.21 Million | +8.83% |
| 2021-12-31 | $1.11 Million | -31.65% |
| 2020-12-31 | $1.62 Million | -35.25% |
| 2019-12-31 | $2.51 Million | -29.58% |
| 2018-12-31 | $3.56 Million | -80.48% |
| 2017-12-31 | $18.24 Million | +36.04% |
| 2016-12-31 | $13.41 Million | +47.31% |
| 2015-12-31 | $9.10 Million | -18.58% |
| 2014-12-31 | $11.18 Million | -19.10% |
| 2013-12-31 | $13.82 Million | +948.79% |
| 2012-12-31 | $1.32 Million | +8.51% |
| 2011-12-31 | $1.21 Million | -- |
About GlucoTrack Inc
GlucoTrack, Inc., a medical device company, focuses on the development of an implantable continuous blood glucose monitor (CBGM) for people with diabetes in the United States. The company develops the GlucoTrack CBGM, a long-term implantable blood-based CBGM for use by Type 1 diabetes patients and insulin-dependent Type 2 diabetes patients. The company was formerly known as Integrity Applications… Read more